With careful planning and systematic assessment of the social value and risks, we believe it can be ethical to conduct some placebo-controlled trials of vaccine candidates for COVID-19 even after we have an efficacious vaccine.
Article COVID-19 vaccine trial ethics once we have efficacious vaccines
Article Ethical considerations for epidemic vaccine trials
Article The Ethics of Continuing Placebo in SARS-CoV-2 Vaccine Trials